Locally-advanced prostate cancer in the elderly

Should we revisit our treatment paradigms?

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Prostate cancer (PCa) represents the most common malignancy in adult males with an estimated number of 280 000 newly diagnosed cases only in the United States in 2015. Due to the introduction of PSA in clinical practice, the majority of the patients are currently diagnosed with organ-confined and sometimes indolent disease. However, a nonnegligible proportion of individuals are still diagnosed with locally-advanced tumors. In their recently published article, Bekelman et al. focused on elderly patients with locally-advanced PCa in the attempt to determine the best treatment approach in this patient category, and concluded that, even in these individuals, androgen deprivation therapy (ADT) plus radiotherapy (RT) may confer a survival benefit relative to ADT alone. The importance of the current article resides in the fact that it focuses on a patient population that has not been, or has been only scarcely, included in previous studies on the same topic.

Original languageEnglish
Pages (from-to)769-770
Number of pages2
JournalAsian Journal of Andrology
Volume17
Issue number5
DOIs
Publication statusPublished - Sep 1 2015

Fingerprint

Prostatic Neoplasms
Androgens
Therapeutics
Neoplasms
Radiotherapy
Survival
Population

ASJC Scopus subject areas

  • Urology

Cite this

@article{34666df1973e49fd8c2d728fd01db50c,
title = "Locally-advanced prostate cancer in the elderly: Should we revisit our treatment paradigms?",
abstract = "Prostate cancer (PCa) represents the most common malignancy in adult males with an estimated number of 280 000 newly diagnosed cases only in the United States in 2015. Due to the introduction of PSA in clinical practice, the majority of the patients are currently diagnosed with organ-confined and sometimes indolent disease. However, a nonnegligible proportion of individuals are still diagnosed with locally-advanced tumors. In their recently published article, Bekelman et al. focused on elderly patients with locally-advanced PCa in the attempt to determine the best treatment approach in this patient category, and concluded that, even in these individuals, androgen deprivation therapy (ADT) plus radiotherapy (RT) may confer a survival benefit relative to ADT alone. The importance of the current article resides in the fact that it focuses on a patient population that has not been, or has been only scarcely, included in previous studies on the same topic.",
author = "Giovanni Lughezzani and Buffi, {Nicol{\'o} Maria}",
year = "2015",
month = "9",
day = "1",
doi = "10.4103/1008-682X.151394",
language = "English",
volume = "17",
pages = "769--770",
journal = "Asian Journal of Andrology",
issn = "1008-682X",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Locally-advanced prostate cancer in the elderly

T2 - Should we revisit our treatment paradigms?

AU - Lughezzani, Giovanni

AU - Buffi, Nicoló Maria

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Prostate cancer (PCa) represents the most common malignancy in adult males with an estimated number of 280 000 newly diagnosed cases only in the United States in 2015. Due to the introduction of PSA in clinical practice, the majority of the patients are currently diagnosed with organ-confined and sometimes indolent disease. However, a nonnegligible proportion of individuals are still diagnosed with locally-advanced tumors. In their recently published article, Bekelman et al. focused on elderly patients with locally-advanced PCa in the attempt to determine the best treatment approach in this patient category, and concluded that, even in these individuals, androgen deprivation therapy (ADT) plus radiotherapy (RT) may confer a survival benefit relative to ADT alone. The importance of the current article resides in the fact that it focuses on a patient population that has not been, or has been only scarcely, included in previous studies on the same topic.

AB - Prostate cancer (PCa) represents the most common malignancy in adult males with an estimated number of 280 000 newly diagnosed cases only in the United States in 2015. Due to the introduction of PSA in clinical practice, the majority of the patients are currently diagnosed with organ-confined and sometimes indolent disease. However, a nonnegligible proportion of individuals are still diagnosed with locally-advanced tumors. In their recently published article, Bekelman et al. focused on elderly patients with locally-advanced PCa in the attempt to determine the best treatment approach in this patient category, and concluded that, even in these individuals, androgen deprivation therapy (ADT) plus radiotherapy (RT) may confer a survival benefit relative to ADT alone. The importance of the current article resides in the fact that it focuses on a patient population that has not been, or has been only scarcely, included in previous studies on the same topic.

UR - http://www.scopus.com/inward/record.url?scp=84940765780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940765780&partnerID=8YFLogxK

U2 - 10.4103/1008-682X.151394

DO - 10.4103/1008-682X.151394

M3 - Article

VL - 17

SP - 769

EP - 770

JO - Asian Journal of Andrology

JF - Asian Journal of Andrology

SN - 1008-682X

IS - 5

ER -